Prognostic Impact of Recreational Drug Use on 1-Year Outcomes in NSTEMI and STEMI Patients.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Aboujaoude Michael, Hamache Nefissa, Dillinger Jean Guillaume, Trimaille Antonin, Bouleti Claire, Delmas Clément, Schurtz Guillaume, Houssany-Pissot Sonia, Vasram Reza Rossanaly, Bonnet Guillaume, Millischer Damien, Thuaire Christophe, Roubille François, Noirclerc Nathalie, Andrieu Stéphane, Fauvel Charles, Mirailles Raphael, Hudelo Julien, Gonçalves Trecy, Florence Jeremy, Unger Alexandre, Singh Manveer, Gall Emmanuel, Lafont Alexandre, Toupin Solenn, Menezes Lynette, Vicaut Eric, Henry Patrick, Pezel Théo, ADDICT-ICCU Investigators
Аннотация
OBJECTIVES: The authors evaluated the association between recreational drug use and major adverse cardiovascular events (MACE) 1 year after intensive cardiac care unit (ICCU) admission in ACS patients.
METHODS: The Addiction in Intensive Cardiac Care Units study systematically screened all patients admitted to ICCUs across 39 French centers (April 7-22, 2021) via prospective urinary testing. The primary outcome was MACE, defined as cardiovascular death, nonfatal myocardial infarction, or stroke. One-year follow-up was collected through clinical visits or direct contact between patients and cardiologists, concluding in June 2022. Outcomes were adjudicated by an independent cardiology committee. The prognostic impact of recreational drug use on MACE was assessed using multivariable Cox proportional hazards models, validated by propensity matching.
RESULTS: Of 712 ACS patients, 13.5% had recreational drug detection. At 1 year, MACE occurred in 7.0%, with higher rates among drug-positive vs drug-negative patients (12.5% vs 6.2%). Recreational drug use was associated with increased MACE (HR: 2.70; 95% CI: 1.30-5.57; P = 0.013). This association was significant in STEMI (HR: 4.11; 95% CI: 1.60-10.5; P = 0.005) but not in non-ST-elevation myocardial infarction patients. Propensity matching confirmed this in STEMI patients (HR: 3.39; 95% CI: 1.19-9.62; P = 0.022).
CONCLUSIONS: Recreational drug use was associated with increased 1-year MACE risk in ACS patients, particularly STEMI, supporting routine drug screening.